Lung Cancer
Thomas J. Lynch, Jr, MD
Yale Cancer Center
Pioneer of personalized medicine
  • Director, Yale Cancer Center and Physician-in-Chief, Smilow Cancer Hospital at Yale-New Haven.
  • Pioneered the use of molecular testing for mutations in the epidermal growth factor receptor (EGFR) gene to select patients who can benefit from targeted lung cancer therapies.
  • Internationally known for his leadership in the development of novel therapies for the treatment of lung cancer.
  • Pioneer in the field of personalized medicine.
Program Information:
Nominate
Sponsor
News
Previous Inductees:
2013 | 2014
2015 | 2016
2017
Connect: